Warning: Some posts on this platform may contain adult material intended for mature audiences only. Viewer discretion is advised. By clicking ‘Continue’, you confirm that you are 18 years or older and consent to viewing explicit content.
I’d take that €4B number with a grain of salt: Had the EU ordered fewer the price per vaccine would’ve been higher which is perfectly sensible not just because of economies of scale but also because a large chunk of the cost was one-off, not per-dose, costs. Development, testing etc.
As to donating the doses: It’s probably complicated, e.g. the BioNTech stuff requires sub-zero cooling which isn’t exactly easy to ensure when you’re a developing country.
I’d take that €4B number with a grain of salt: Had the EU ordered fewer the price per vaccine would’ve been higher which is perfectly sensible not just because of economies of scale but also because a large chunk of the cost was one-off, not per-dose, costs. Development, testing etc.
As to donating the doses: It’s probably complicated, e.g. the BioNTech stuff requires sub-zero cooling which isn’t exactly easy to ensure when you’re a developing country.
Doesn’t sub zero just mean below zero temperatures?
-60 to -80C for long-term storage, two weeks at -15 to -25 (those are standard pharmaceutical freezer temperatures, five days at fridge temperatures.